Company executives at Pfizer and Wyeth aren't revealing where merger-related job cuts would be.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Related links
Related links
Related links in Nature Research
Pfizer to buy Wyeth in -billion deal
Industry shifts focus to immunology and cancer
Related external links
Rights and permissions
About this article
Cite this article
Kaplan, K. No drug for job haemorrhage. Nature 457, 924 (2009). https://doi.org/10.1038/nj7231-924b
Published:
Issue Date:
DOI: https://doi.org/10.1038/nj7231-924b